#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2496	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2281	316.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1477	1477	C	321	C,A	259,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3960	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3837	305.8	0	.	n	.	0	T695C	SNP	695	695	T	1254	1254	C	305	C,T	251,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3960	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3837	305.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1896	1896	A	359	A,C	307,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3960	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3837	305.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2530	2530	C	326	C,CA	257,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3960	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3837	305.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3156	3156	T	322	T,C	254,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3960	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3837	305.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2604	2604	A	332	A	276	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	V36A	NONSYN	106	108	GTG	691	693	GCG	54;53;53	G;C,G;G	46;44,1;45	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	733	735	CGG	57;57;57	C;G;G	46;49;48	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	S68L	NONSYN	202	204	TCG	787	789	TTG	55;55;55	T,G;T;G,T	41,1;43;40,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	A90V	NONSYN	268	270	GCG	853	855	GTT	56;55;55	G;T;T	44;44;44	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	I105V	NONSYN	313	315	ATT	898	900	GTT	53;51;51	G;T;T	46;42;43	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	N125T	NONSYN	373	375	AAT	958	960	ACC	50;50;50	A;C;C	42;44;43	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	R135C	NONSYN	403	405	CGT	988	990	TGT	50;50;50	T;G;T,G	44;41;40,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	K151E	NONSYN	451	453	AAA	1036	1038	GAA	48;48;50	G;A;A	41;42;45	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1039	1041	AAC	50;50;49	A,C;A;C	44,1;44;39	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	A172T	NONSYN	514	516	GCG	1099	1101	ACA	47;47;47	A;C;A	35;39;39	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1108	1110	GAA	44;44;44	G;A;A	37;38;40	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1111	1113	ACC	44;44;44	A;C;C	35;39;39	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1117	1119	GTC	44;44;43	G,T;T;C,T	36,1;38;37,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1147	1149	ACG	41;41;41	A;C;G	37;36;36	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1183	1185	AAC	39;39;40	A,G;A;C,A	34,1;34;36,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1243	1245	TTG	40;40;40	T;T;G	36;34;30	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1300	1302	ACC	41;41;41	A;C;C,G	31;31;30,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1303	1305	GAC	41;41;41	G;A,C;C	31;27,1;27	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1312	1314	GCG	41;41;40	G;C;G	31;27;27	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1348	1350	GCT	37;38;38	G;C;T,G	32;27;26,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	210	folP	858	858	91.61	folP.l6.c4.ctg.1	2078	30.0	1	SNP	p	R230S	1	.	.	688	690	AGC	1273	1275	AGC	40;40;41	A,C;G;C,A	28,1;31;30,1	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	848	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3780	66.8	1	SNP	p	S91F	0	.	.	271	273	TCC	766	768	TCC	48;47;47	T;C;C	42;42;43	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	848	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3780	66.8	1	SNP	p	D95N	0	.	.	283	285	GAC	778	780	GAC	46;47;47	G;A;C	40;41;43	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	848	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3780	66.8	1	SNP	p	D95G	0	.	.	283	285	GAC	778	780	GAC	46;47;47	G;A;C	40;41;43	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	320	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1828	52.2	1	SNP	p	G45D	1	.	.	133	135	GAC	661	663	GAC	82;82;83	G;A,G;C	69;69,1;72	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	236	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1885	37.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	794	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3277	72.0	1	SNP	p	D86N	0	.	.	256	258	GAC	705	707	GAC	78;78;78	G;A,C;C	61;60,1;62	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	794	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3277	72.0	1	SNP	p	S87W	0	.	.	259	261	AGT	708	710	AGT	74;75;76	A;G;T	59;59;63	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	794	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3277	72.0	1	SNP	p	S87R	0	.	.	259	261	AGT	708	710	AGT	74;75;76	A;G;T	59;59;63	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	794	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3277	72.0	1	SNP	p	S87I	0	.	.	259	261	AGT	708	710	AGT	74;75;76	A;G;T	59;59;63	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	794	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3277	72.0	1	SNP	p	S88P	0	.	.	262	264	TCC	711	713	TCC	76;75;75	T;C;C	61;65;60	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	664	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3200	61.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1825	1827	GGC	103;103;104	G;G,T;C	85;88,1;86	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1487	1489	GCA	98;99;98	G;C,A;A,C	83;80,1;82,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1490	1492	ATC	98;98;99	A,C;T,G;C	85,1;81,1;82	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1502	1504	GTG	100;101;101	G;T,G;G,T	85;79,2;84,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1502	1504	GTG	100;101;101	G;T,G;G,T	85;79,2;84,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2006	2008	ACC	69;70;70	A;C;C	58;60;60	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2060	2062	GCG	61;60;61	G;C,G;G	52;44,1;47	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2060	2062	GCG	61;60;61	G;C,G;G	52;44,1;47	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2183	2185	GGC	57;58;58	G;G;C	45;48;47	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2192	2194	GGC	59;59;60	G;G;C	48;49;51	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2747	63.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2210	2212	CCG	59;59;59	C;C;G	50;50;48	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	856	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3578	71.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1856	1858	CTG	74;74;74	C;T,G;G	54;55,1;59	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	380	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2256	50.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	821	821	C	63	C,A	49,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	642	644	GAA	89;90;89	G,A;A;A,C	71,1;74;74,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	S46G	NONSYN	136	138	AGC	666	668	GGC	86;86;86	G;G;C	72;71;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	672	674	GGA	88;88;88	G;G;A	73;73;73	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	T87A	NONSYN	259	261	ACT	789	791	GCT	80;80;81	G;C;T	65;65;65	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	795	797	AGC	79;78;77	A;G,A;C	64;61,1;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	887	888	CG	72;72	C;G	57;58	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	890	892	CAG	72;72;72	C;A,T;G,A	55;56,1;58,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	894	896	AAA	73;74;74	A;A,C;A	57;61,1;57	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	957	959	GAA	75;74;74	G,C;A;A	59,1;60;62	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	981	983	GCA	76;77;76	G,C;C;A	58,1;60;58	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1173	1175	ACT	75;76;76	A,C;C;T,C	64,1;64;62,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1182	1184	ATG	79;79;80	A;T;G	66;66;67	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1296	1298	GCA	74;74;74	G;C;A	65;66;64	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1299	1301	ACG	74;74;74	A;C;G	66;66;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1302	1304	GGG	71;71;71	G;G;G	64;66;65	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1305	1307	GTT	71;70;71	G;T;T	63;62;65	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1365	1367	GTA	73;73;73	G;T;A	65;65;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1404	1406	ACT	78;79;78	A,C;C;T	66,1;71;69	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1410	1412	GAT	79;79;80	G;A;T	69;68;69	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1422	1424	CAC	85;84;84	C;A;C	72;69;73	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	1	SNP	p	G120K	1	.	.	358	360	AAG	887	889	CGG	72;72;72	C;G;G	57;58;59	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	1	SNP	p	D121N	0	.	.	361	363	GAC	890	893	CGC	72;72;73	C;G,A;C	55;58,1;62	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	468	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1844	72.3	1	SNP	p	A121D	1	.	.	361	363	GAC	890	893	CGC	72;72;73	C;G,A;C	55;58,1;62	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	1468	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5505	79.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2338	2340	CAT	60;61;61	C,A;A,C;T	53,1;51,1;50	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	244	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1459	50.0	1	SNP	p	V57M	1	.	.	169	171	ATG	724	726	ATG	84;85;85	A;T;G	72;73;74	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
